PHIO

#4756
Phio Pharmaceuticals Corp. Common Stock
1.2900 USD
+4.03%
부문: 헬스케어
베이스: USD
수익 통화: USD
일일 변동 비율
1.2600
1.3000
년간 변동
0.9780
1.3500
일일 변동
+4.03%
월간 변동
+6.61%
6달 변화
+8.40%
년간 변동율
+8.40%
이전 종가
1.2400
Open
1.2600
Bid
Ask
Low
1.2600
High
1.3000
양
42
Open full chart

Financials

Overview 성명 Statistics
Quarterly Annual
  • Market Capitalization 14.9863 M
  • Employee 6
  • Founded 2011
  • CEO N/A
  • Website www.phiopharma.com
  • Headquarter Delaware, United States
  • FIGI BBG0024FKD97
  • Industry Technology
총매출
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-0.72
Price to sales ratio
—

Phio Pharmaceuticals Corp

Phio Pharmaceuticals Corporation is a US clinical stage biotechnology company developing its INTASYL siRNA in immuno-oncology. Formerly known as RXi Pharmaceuticals, the company's name was changed to Phio Pharmaceuticals in 2018.

뉴스